AzTrials
AzTrials

Gastrointestinal MicrobiomeBLAMNCT06126094

Benefits of Alcoholic Hangover Medicine

A study testing Myrkl and dextrin in people with Gastrointestinal Microbiome, run by The Gut Microbiome Center (Centar za crijevni mikrobiom) at 1 site in Croatia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Myrkl is advertised as a dietary supplement for use before alcohol consumption that is effective in prevention of side effects during the next day. With this research, the investigators want to determine the impact of the mentioned dietary supplement on the intestinal microbiome. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Gastrointestinal Microbiome
What is being tested?
Myrkl and dextrin
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2 participants
Where
1 siteCroatia
Study dates
31 Oct 2023to 20 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • fraternal twins who live and work together

Who cannot join

  • consumption of other probiotics, antibiotics 30 days before the research
  • Inability to drink alcohol

Trial locations and contacts

1 site in 1 country.

Andrija Karačić, dr.med contact

+385981373344

andrija@ccm.hr

Ira Renko, MS contact

+385993373343

info@ccm.hr

Croatia1 site
  • Gut Microbiome Center

    Zagreb, 10000

    Andrija Karačić, dr.med, +385981373344, andrija@ccm.hr

    Ira Renko, MSC, +385993373343, info@ccm.hr

Other trials in Croatia

About this study

Official title: Benefits of Alcoholic Hangover Medicine Myrkl

Myrkl is advertised as a dietary supplement for use before alcohol consumption that is effective in prevention of side effects during the next day. With this research, the investigators want to determine the impact of the mentioned dietary supplement on the intestinal microbiome. For this purpose, the research was designed in three phases before, during and after the research as a double blind trial. In doing so, the subjects take a stool sample before and after the intervention and during the intervention, fill out questionnaires and undergo cognitive tests. At the same time, they give a blood sample after the intervention. After the results of the analysis are due, the researchers enter the data into the for that the predicted Access table (rel. representation of genera/genera/species, average results by questionnaires). The entered data is processed as part of statistical analysis.

Read the detailed description

A "cure" for an alcoholic hangover has been put on the market, that is, it relieves the symptoms and ailments hangover alcohol (https://www.myrkl.com/). This medicine contains probiotic strains in its formulation (Bacillus subtilis, Bacillus coagulans). Myrkl has been advertised as a dietary supplement for use before alcohol consumption that is effective in prevention of side effects during the next day. The manufacturer claims that after taking Myrkl participants feel fresh even after a "long night". In addition to the probiotics mentioned above, Myrkl also contains L-cysteine and vitamins B12. The formula is said to be activated in the intestines. The manufacturer states that 77 of users are satisfied product and how it is completely natural. It is recommended to take two capsules two hours before consumption alcohol. With this research, the investigators wanted to determine the taxonomic changes within the intestinal microbiome after the intervention. In addition, the investigators wanted to determine changes in the subjective impression of a hangover measured by a validated questionnaires. The research was designed as a double-blind placebo-controlled intervention study twins (controlled for age, sex, cohabitation, genetics).

Before the start of the intervention, the test subjects will be instructed to eat the same diet during the 48 hours before beginning of each intervention. The subjects will keep a food diary for two days in order to accurately evaluated the nutritional status. The key is that both subjects consume the same food in both times before the intervention. The food intake itself is determined by the respondents independently.

After the intervention, the respondents will fill out a selection of questionnaires created in the form using the link a special online document (Project BLAM, Forms, Microsoft, USA) that will evaluate theirs alcoholic hangover. In order to evaluate the dynamics of the hangover, the test subject will again every 2 hours fill out the questionnaire (6 evaluations in total - waking up, 2, 4, 6, 8 and 10 hours after waking up). The result of each questionnaire is obtained by calculating the arithmetic mean of all answers (0-5, 0-10). Using all questionnaire was approved by the publisher and the English version will be used. Questionnaires were used https://forms.office.com/Pages/DesignPageV2.aspx subpage=design\&FormId=hN0190t4UESOZ73jM ACw9LJ5ROlYHHVMuwYZ6ti3GaRUOEZEUVhSNDlPVjMwT1ZJVUFWTjQ3QldYRC4u\&Token=fcda6871a b5d4009b779536b561d8dfb :

  • Alcohol Hangover Questionnaire (AHQ)
  • Alcohol Hangover Severity Scale (AHSS)

Materials The subject of the test will be supplementation with a precise probiotic for hangovers (Myrkl, De Fair

Medical, Stockholm, Sweden). This formulation contains AB001™, and one capsule (800mg) consists of:

  • 560 mg of naturally fermented rice bran
  • Bacillus subtilis
  • B. coagulans
  • L-cysteine
  • dextrin
  • 36 mg of excipients: magnesium stearate salts, calcium phosphate, potassium phosphate The CFU per strain in the formulation is minimal (ask the manufacturer). The probiotic comes in capsule form blister, stored at room temperature. An 800 mg capsule containing dextrin (maltodextrin) will be used for the placebo. It's a placebo dose also two capsules of 800 mg each.

The recommended intake will be two capsules exactly two hours before alcohol consumption. Control entry will be through a video diary.

Methods Analyzes of the intestinal microbiome Since the impact of probiotics on the intestinal microbiome will be measured before and after the investigated intervention two analyzes of the intestinal microbiome will be carried out on Day 0, i.e. on the day of the start of the intervention and Day 1, the day after the intervention. The BIOMES sampling kit will be used for the analysis, and intest.pro. The analysis will be performed on a sample of the first morning stool that the test subjects will take independently in home conditions Day 0 and Day 1. Samples will be delivered to the company's laboratory by logistics service BOMES (BIOMES GmbH, Wildau, Germany) where next-generation sequencing of 16s will be performed ribosomal RNA and bioinformatic analysis of the results (review of taxonomy and functionality). These results will be delivered to the researchers.

Statistical analysis Statistical data processing will analyze the changes in both test subjects, B1 and B2, taking taking into account whether the intervention was verum (V) or placebo (P). Upon maturity descriptive and inferential statistics will be made of the results using the appropriate program (Statistica, Palo Alto, USA). For normally distributed data, use the Kolmogorov-Smirnoff test will be the average and standard deviation, and for the second group the median and percentiles. To analyze the hypothesis treatment Mann-Whitney test and paired t-test will be used. Statistically significant will be considered p- values less than 0.05.

The research is divided into three phases - before the intervention, intervention, and after interventions. Alcohol is administered during the intervention. The respondents choose the drink they want consumed in two categories: welcome drink - žestice, brandy, liqueur, wormwood, evening drink - gemišt, wine, beer, gin and tonic, juice and juice.

Before intervention:

  • the test subjects took the tests and research material at the Sky Office reception
  • 48 hours before the intervention, they monitor their diet through a diary
  • both test subjects eat absolutely identical food before each intervention
  • on Day 0 they take the first stool sample (test A, test C), ideally the morning stool/the first stool
  • do not consume any alcohol
  • two hours before the planned intervention, say 6:30 p.m., that means around 4:30 p.m. they take a capsule with 1 dl water

Intervention:

  • the subjects come to the recording on Day 0 around 18.00 in the CCM area, the conference room
  • from 18.00 to 18.30 is preparation for recording
  • at 6:30 p.m. the first sip of alcohol follows - a welcome drink (zestica, liqueur)
  • around 6:40 p.m. the drinks of the evening follow (gemišt, gin and tonic, beer, wine)
  • the first interview follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
  • around 7:00 p.m., the first cut follows - a welcome drink
  • around 7:10 p.m., another drink in the evening
  • a second conversation follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
  • during the second interview, the interviewees have the opportunity to eat something small (meal/sandwich)
  • around 19.10 the last drink of the evening goes, possibly. and a welcome drink
  • a third interview follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
  • Human Lab takes a blood sample to determine blood ethanol, which CCM employees will take to HKA KBSD same evening immediately

After the intervention:

  • after waking up and then within two hours, the subjects fill out the questionnaire: https://forms.office.com/Pages/ResponsePage.aspx?id=hN0190t4UESOZ73jMACw9LJ5ROlYH HVMuwYZ6ti3GaRUOEZEUVhSNDlPVjMwT1ZJVUFWTjQ3QldYRC4u
  • the morning stool or the first stool after the intervention should be sampled on Day 1
  • on Day 1 around 18.00 arrival for filming at the same place
  • from 18.00 to 19.00 a conversation about how they feel and whether they think they received a placebo or a probiotic.

After the end of the cycle and the arrival of the results of the analysis, the researchers enter the data into the for that predicted Access table (rel. representation of genera/genera/species, average results by questionnaires). The entered data is processed as part of the statistical analysis in the previously explained manner. In these last steps student, research assistants may be involved.

Being tested
Myrkl, dextrin
Keywords
Microbiota, Probiotics, Alcohol, Cognitive behaviour

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MyrklDietary supplement

    The subject of the test will be supplementation with precise probiotic for hangovers (Myrkl, De Fair) in the form of one pill of 800 mg

  • dextrinDietary supplement

    The subject of the test will be supplementation with placebo (maltodextrin) in the form of two pills (each 400 mg)

Study groups in NCT06126094
Study groupRoleWhat they receive
ProbioticExperimentalParticipants will consume 800 mg of probiotic Myrkl before consuming alcohol in the form of one capsule. (Myrkl, De Fair Medical, Stockholm, Sweden). This formulation contains AB001™, and one capsule (800mg) consists of: * 560 mg of naturally fermented rice bran * Bacillus subtilis * B. coagulans * L-cysteine * dextrin * 36 mg of excipients: magnesium stearate salts, calcium phosphate, potassium phosphate
Receives: Dietary Supplement: Myrkl
PlaceboExperimentalThe subject who consumed 800 mg of placebo- dextrin (maltodextrin) in the form of two capsules before consuming alcohol.
Receives: Dietary Supplement: dextrin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gut microbiome composition

    The impact of Myrkl on gut microbiome shall assessed through monitoring of relative taxonomic abundance of bacteria that compose gut microbiota from samples taken day before the intervention and after the intervention.

    The composition of the intestinal microbiota will be determined by sequencing the 16s rRNA bacteria in the stool sample. Subjects take a sample with a sterile cotton swab by wiping stool with toilet paper in their home on a given day research. The sample is stored in a tube with a buffer liquid so that the sample can be stored and transported at room temperature temperature. The test sample is transported by air to the laboratory of Biomes NGS Gesellschaft mit beschränkter Haftung, Wildau, Germany.

    Measured: one month

Secondary outcomes (1)
  1. the subjective impression of a hangover

    In order to validate the subjective impression of a hangover, the subjects will fill out the Alcohol Hangover Questionnaire (AHQ) several times.

    Measured: one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Nov 2023
  2. Study start31 Oct 2023 (estimated)
  3. Primary completion1 Dec 2023 (estimated)
  4. Study completion20 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Crossover
Model description
The test subjects receive capsules of probiotics and palcebo in marked bags and take one or the other arbitrarily without being told what is in which bag. Likewise, the researchers do not know whether the subjects took the probiotic or the placebo.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
2 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06126094
Sponsor's protocol ID
BLAM123
Acronym
BLAM
Status last verified
Oct 2023
First submitted
31 Oct 2023
Last updated
13 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Myrkl and dextrin in people with Gastrointestinal Microbiome, run by The Gut Microbiome Center (Centar za crijevni mikrobiom) at 1 site in Croatia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Croatia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Andrija Karačić, dr.med (+385981373344, andrija@ccm.hr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gut microbiome composition (time frame: one month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in